Bearish Crab. The 4th leg of the crooked W appears to have terminated at the 1.618.
The Crab is a reversal pattern which causes price exhaustion. It is also an Extension pattern as the 4th leg ends above X.
There is a gap below price that may or may not provide support.
PE ratio is high, especially for this sector. There is no dividend so I am wondering why someone would hold on to this right now. But they might.
Price is just above the .236 of the trend up
No recommendation
EPS (FWD)
2.73
PE (FWD)
92.39
Div Rate (TTM)
-
Yield (TTM)
-
Short Interest
5.26%
Market Cap
$9.06B
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
The Crab is a reversal pattern which causes price exhaustion. It is also an Extension pattern as the 4th leg ends above X.
There is a gap below price that may or may not provide support.
PE ratio is high, especially for this sector. There is no dividend so I am wondering why someone would hold on to this right now. But they might.
Price is just above the .236 of the trend up
No recommendation
EPS (FWD)
2.73
PE (FWD)
92.39
Div Rate (TTM)
-
Yield (TTM)
-
Short Interest
5.26%
Market Cap
$9.06B
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.